• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE Back to Search Results
Model Number 777426
Device Problem Biocompatibility (2886)
Patient Problems Abdominal Pain (1685); Pain (1994); Urinary Retention (2119); Hematuria (2558)
Event Date 07/13/2021
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.The device was not returned.
 
Event Description
It was reported that the patient was admitted to the hospital on (b)(6) 2021 due to left lumbar abdominal pain for 2 days worsened for 2 hours and received transurethral holmium laser lithotripsy combined with pneumatic ballistic lithotripsy and left ureteral stent implantation from (b)(6) 2021.Also ureteral stent catheter was indwelled for internal stent drainage.The operation went smooth and the internal stent tube had drained smoothly.Patient was discharged from the hospital on (b)(6) 2021.In the morning of (b)(6) 2021, the patient repeatedly experienced with urinalgia, bright red gross hematuria and sense of urinary insufficiency.From (b)(6) 2021, the patient went to the hospital again.The ureteral stent was completely removed and a small amount of fine gravel powder adhered to its surface with bleeding.Symptomatic treatment such as anti-infection had been given after the operation and symptoms were significantly relieved after the removal of ureteral stents.On (b)(6) 2021, the patient was discharged.
 
Manufacturer Narrative
The reported event is inconclusive since no sample was returned.A potential root cause for this event could be, "material selection".The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: "potential complications: potential complications associated with retrograde/antegrade positioning of indwelling ureteral stents include the following: edema ; stone formation ; peritonitis ; extravasation ; ureteral refl ux ; stent dislogdgement, fragmentation, migration, occlusion ; fistula formation ; loss of renal function; hemorrhage; pain/discomfort; tent encrustation; hydronephrosis; perforation of kidney, renal; ureteral erosion; infection pelvis, ureter and/or bladder & urinary symptoms" h11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that the patient was admitted to the hospital on (b)(6) 2021 due to left lumbar abdominal pain for 2 days worsened for 2 hours and received transurethral holmium laser lithotripsy combined with pneumatic ballistic lithotripsy and left ureteral stent implantation (b)(6).Also ureteral stent catheter was indwelled for internal stent drainage.The operation went smooth and the internal stent tube had drained smoothly.Patient was discharged from the hospital on (b)(6).In the morning of july 13, the patient repeatedly experienced with urinalgia, bright red gross hematuria and sense of urinary insufficiency.From (b)(6), the patient went to the hospital again.The ureteral stent was completely removed and a small amount of fine gravel powder adhered to its surface with bleeding.Symptomatic treatment such as anti-infection had been given after the operation and symptoms were significantly relieved after the removal of ureteral stents.On (b)(6), the patient was discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE
Type of Device
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
yonic anderson
8195 industrial blvd
covington 30014
7707846100
MDR Report Key12569765
MDR Text Key274542334
Report Number1018233-2021-06174
Device Sequence Number1
Product Code FAD
UDI-Device Identifier10801741014489
UDI-Public(01)10801741014489
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K983498
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number777426
Device Catalogue Number777426
Device Lot NumberNGEP4412
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/13/2021
Initial Date FDA Received10/04/2021
Supplement Dates Manufacturer Received03/02/2022
Supplement Dates FDA Received03/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/28/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-